Alimera Sciences
1 follower
Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...
Industries
Headquarters
Employees
Links
Org chart
Rick Eiswirth
President, CEO & Interim CFO
Rick Eiswirth
Collapse
David Holland
CMO & SVP, Corporate Communications & Managed Markets
Russell Skibsted
CFO & SVP
David Dyer
Chief Retina Specialist
Steve Gill
Vice President, Thought Leader Engagement At Alimera Sciences
Christopher Visick
Vice President, General Counsel
Laura Cegala Sphr, Gphr
Vice President, Human Capital
Benjamin Simon
Senior Director, Global Quality Assurance
Brittany Underhill
Associate Director, Financial Reporting
Larry Karner
Vice President, Managed Markets
Mike Padilla
Vice President Of Global Marketing/head Of Commercial Excellence
Riz Siddiqi
Medical Director, UK & Eire
Steve Morris
Vice President , Medical Director Uk, Head Of Medical Affairs Europe
Trey Kincaid
Senior Director, Finance & Corporate Controller
Bill Garner
Executive Director Marketing
Liz Michael
Associate Director Strategic Alliances & Program Management
Diane Reeves
Business Manager
Sergei Donskihh
European IT Manager
Ben Flagler
Regional Sales Director
Bryce Werner
Regional Sales Director
Tom Sinnamon
Region Director Of Sales
Catherine Griffiths
Market Access Manager, UK & Ireland
Deirdre O Reilly
Associate Director Corporate Compliance Training
David Gregory
Business Analytics Manager, EMEA
Kotaro Sai
Business Analytics Manager
Kapil Kumar
Clinical Account Specialist & Field Sales Trainer
Similar companies
Code.org
10 followers
InStride
3 followers
KIPP Schools
2 followers
Catalyst Pharmaceuticals
2 followers
BASIS Independent Schools
1 follower
Alloy Therapeutics
2 followers
ParentSquare
1 follower
Genesis Therapeutics
1 follower
Instil Bio
1 follower
Bristol-Myers Squibb
165 followers
Shakopee Public Schools
30 followers
Discover companies